DBV Technologies (DBVT) Capital Expenditures (2020 - 2026)

DBV Technologies (DBVT) posted quarterly Capital Expenditures of $400000.0 for Q2 2026, little changed on a QoQ basis from $400000.0 in Q1 2026.

DBV Technologies (DBVT) Capital Expenditures (2020 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Capital Expenditures for 7 consecutive years, with $400000.0 the latest figure, recorded in Q2 2026.

  • Quarterly Capital Expenditures changed N/A year-over-year to $400000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.3 million (up 391.51% YoY) and the FY2025 annual result came in at $532000.0, down 77.25% from the prior year.
  • Capital Expenditures was little changed at $400000.0 in Q2 2026 per DBVT's latest filing, from $400000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for DBVT reached as high as $1.3 million in Q1 2024 and fell as low as -$125000.0 in Q4 2024.
  • A 5-year average of $318812.5 and a median of $295000.0 in 2022 frame the typical range for Capital Expenditures.
  • Annual changes were most pronounced in 2022 — Capital Expenditures jumped 2969.23% — and 2024, when it sank 135.51%.
  • Year by year, Capital Expenditures stood at $12000.0 in 2022, then soared by 2833.33% to $352000.0 in 2023, then plunged by 135.51% to -$125000.0 in 2024, then jumped by 398.4% to $373000.0 in 2025, then rose by 7.24% to $400000.0 in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods registered $400000.0, $400000.0, and $373000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -8,939.03
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 43.25 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 133.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 230.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 786,000.00
10 DBV Technologies 267.50 Mn 92.60 Mn - 400,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 400,000.00
Jun 30, 2026 400,000.00
Mar 31, 2026 400,000.00
Mar 31, 2026 400,000.00
Dec 31, 2025 373,000.00
Dec 31, 2025 373,000.00
Sep 30, 2025 159,000.00
Sep 30, 2025 159,000.00
Dec 31, 2024 -125,000.00
Dec 31, 2024 -125,000.00
Sep 30, 2024 396,000.00
Sep 30, 2024 396,000.00
Jun 30, 2024 732,000.00
Jun 30, 2024 732,000.00
Mar 31, 2024 1.34 Mn
Mar 31, 2024 1.34 Mn
Dec 31, 2023 352,000.00
Dec 31, 2023 352,000.00
Sep 30, 2023 50,000.00
Sep 30, 2023 50,000.00